Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 784-789

  Gurses, Kadri Murat ^a   Tokgozoglu, Lale ^a   Yalcin, Muhammed Ulvi ^a   Kocyigit, Duygu ^a   Dural, Muhammet ^a   Canpinar, Hande ^a   Yorgun, Hikmet ^a   Sahiner, Mehmet Levent ^a   Kaya, Ergun Baris ^a   Akin, Safak ^a   Gurlek, Alper ^a   Guc, Dicle ^a   Aytemir, Kudret ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Endothelial function; Endothelial progenitor cell count; Inflammation; Subclinical atherosclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; VITAMIN D;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DILATATION; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOMODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTOR VARIABLE; PREMENOPAUSE; SUBSTITUTION THERAPY; VASCULAR ENDOTHELIUM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84910647560     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.096     Document Type: Article

References (45)

1. Holick M.F. Vitamin D deficiency. N.Engl. J. Med. 2007, 357:266-281.
2. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 2006, 81:353-373.
3. Norman P.E., Powell J.T. Vitamin D and cardiovascular disease. Circ. Res. 2014, 114:379-393.
4. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J.Clin. Endocrinol. Metab. 2011, 96:1911-1930.
5. Ergur A.T., Berberoglu M., Atasay B., Siklar Z., Bilir P., Arsan S., et al. Vitamin D deficiency in Turkish mothers and their neonates and in women of reproductive age. J.Clin. Res. Pediatr. Endocrinol. 2009, 1:266-269.
6. ). http://www.tuik.gov.tr/PreHaberBultenleri.do?id=16162last%20accessed.
7. Nichols M., Townsend N., Luengo-Fernandez R., Leal J., Gray A., Scarborough P., Rayner M. European Cardiovascular Disease Statistics 2012, In: S L, ed. 2012 edition.
8. Scragg R., Jackson R., Holdaway I.M., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int. J. Epidemiol. 1990, 19:559-563.
9. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2007, 167:1159-1165.
10. Weishaar R.E., Simpson R.U. Vitamin D3 and cardiovascular function in rats. J.Clin. Invest. 1987, 79:1706-1712.
11. Szeto F.L., Reardon C.A., Yoon D., Wang Y., Wong K.E., Chen Y., et al. Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol. Endocrinol. 2012, 26:1091-1101.
12. Kassi E., Adamopoulos C., Basdra E.K., Papavassiliou A.G. Role of vitamin D in atherosclerosis. Circ. 2013, 128:2517-2531.
13. Kunutsor S.K., Apekey T.A., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur. J. Epidemiol. 2013, 28:205-221.
14. Pittas A.G., Nelson J., Mitri J., Hillmann W., Garganta C., Nathan D.M., et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the diabetes prevention program. Diabetes care 2012, 35:565-573.
15. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J.Clin. Invest. 2002, 110:229-238.
16. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur. Heart J. 1997, 18(Suppl.E):E19-E29.
17. Yiu Y.F., Chan Y.H., Yiu K.H., Siu C.W., Li S.W., Wong L.Y., et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J.Clin. Endocrinol. Metab. 2011, 96:E830-E835.
18. Tarcin O., Yavuz D.G., Ozben B., Telli A., Ogunc A.V., Yuksel M., et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J.Clin. Endocrinol. Metab. 2009, 94:4023-4030.
19. Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53:2112-2119.
20. Witham M.D., Adams F., Kabir G., Kennedy G., Belch J.J., Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK-a randomised controlled trial. Atherosclerosis 2013, 230:293-299.
21. Yiu Y.F., Yiu K.H., Siu C.W., Chan Y.H., Li S.W., Wong L.Y., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227:140-146.
22. Antonopoulos A.S., Margaritis M., Shirodaria C., Antoniades C. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation. Thromb. Haemost. 2012, 108:840-848.
23. Ferrario C. Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil. Vasc. Health Risk Manag. 2009, 5:301-314.
24. Molinari C., Uberti F., Grossini E., Vacca G., Carda S., Invernizzi M., et al. 1alpha,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2011, 27:661-668.
25. Hirata M., Serizawa K., Aizawa K., Yogo K., Tashiro Y., Takeda S., et al. 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy. Nephrol. Dial., Transplant.: Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 2013, 28:1166-1174.
26. Ott C., Raff U., Schneider M.P., Titze S.I., Schmieder R.E. 25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment. Clin. Res. Cardiol.: Off. J. Ger. Cardiac Soc. 2013, 102:299-304.
27. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004, 95:343-353.
28. Cianciolo G., La Manna G., Cappuccilli M.L., Lanci N., Della Bella E., Cuna V., et al. VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif. 2011, 32:161-173.
29. Mikirova N.A., Belcaro G., Jackson J.A., Riordan N.H. Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors. Panminerva Med. 2010, 52:81-87.
30. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2045-2051.
31. Tokgozoglu L. Atherosclerosis and the role of inflammation. Turk Kardiyol. Dernegi arsivi: Turk Kardiyol. Derneginin yayin organidir 2009, 37(Suppl.4):1-6.
32. Giulietti A., van Etten E., Overbergh L., Stoffels K., Bouillon R., Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res. Clin. Pract. 2007, 77:47-57.
33. Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell. Immunol. 2005, 233:115-124.
34. Gunnett C.A., Heistad D.D., Berg D.J., Faraci F.M. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1555-H1562.
35. Krishnamurthy P., Thal M., Verma S., Hoxha E., Lambers E., Ramirez V., et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ. Res. 2011, 109:1280-1289.
36. Fichtlscherer S., Breuer S., Heeschen C., Dimmeler S., Zeiher A.M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J.Am. Coll. Cardiol. 2004, 44:44-49.
37. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43:402-407.
38. Nguyen H., Chiasson V.L., Chatterjee P., Kopriva S.E., Young K.J., Mitchell B.M. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc. Res. 2013, 97:696-704.
39. Ranganathan P., Khalatbari S., Yalavarthi S., Marder W., Brook R., Kaplan M.J. Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis. J.Rheumatol. 2013, 40:1529-1534.
40. Urbina E.M., Williams R.V., Alpert B.S., Collins R.T., Daniels S.R., Hayman L., et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009, 54:919-950.
41. Targher G., Bertolini L., Padovani R., Zenari L., Scala L., Cigolini M., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. 2006, 65:593-597.
42. Reis J.P., von Muhlen D., Michos E.D., Miller E.R., Appel L.J., Araneta M.R., et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 2009, 207:585-590.
43. Blondon M., Sachs M., Hoofnagle A.N., Ix J.H., Michos E.D., Korcarz C., et al. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2639-2645.
44. Sachs M.C., Brunzell J.D., Cleary P.A., Hoofnagle A.N., Lachin J.M., Molitch M.E., et al. Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care 2013, 36:2423-2429.
45. Deleskog A., Piksasova O., Silveira A., Gertow K., Baldassarre D., Veglia F., et al. Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2633-2638.